$1.11
-0.03-2.63%
Last update: Nov 5, 6:50 AM
Sonoma Pharmaceuticals Inc
SNOANASDAQ
Sonoma Pharmaceuticals (SNOA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-0.24 | $-0.31 | $-0.31 |
| Actual | $-0.09 | $-0.33 | $-0.48 | $-0.32 |
| Surprise | — | -37.5% | -54.8% | -3.23% |
| Revenue | ||||
| Estimate | — | $5.6M | $4.3M | $4.3M |
| Actual | $6.4M | $5.6M | $4.3M | $5.6M |
| Surprise | — | -0.08% | +0.44% | +31.6% |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Jun 16, 2026 | $-0.33 | $-0.24 | -37.5 % |
| Q3 | Feb 10, 2026 | $-0.48 | $-0.31 | -54.8 % |
| Q2 | Nov 4, 2025 | $-0.32 | $-0.31 | -3.23 % |
| Q4 | Jun 17, 2025 | $-0.48 | $-0.60 | 20.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Jun 16, 2026 | $5.56M | $5.57M | -0.08 % |
| Q3 | Feb 10, 2026 | $4.35M | $4.33M | 0.44 % |
| Q2 | Nov 4, 2025 | $5.60M | $4.26M | 31.6 % |
| Q1 | Aug 7, 2025 | $4.01M | $4.05M | -0.86 % |
